Stryker is largest orthopedics company and one of the world's leading orthopedic suppliers.
Stryker Corporation is one of the world's largest medical technology companies, with 2025 revenues of approximately $23.4 billion. The Mako SmartRobotics platform — deployed in hip, knee, and partial knee arthroplasty — is the most commercially successful surgical robot in orthopedics history, with over 1,800 installed systems globally generating recurring implant pull-through revenue. Stryker's acquisition of Wright Medical Group in 2020 elevated the company to a top-three position in upper extremity implants. The company's MedSurg and Neurotechnology segment — covering patient handling, emergency medical, endoscopy, and neurovascular intervention — provides revenue diversification that no other pure-play orthopedic company can match.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Acquisitions and divestitures
• Marketing tactics
• Financial results
• Strengths and weaknesses
• Strategic directions
Table of Contents
1. Executive Summary
2. Company Overview and Business Model
3. Strategic Directions
4. Financial Results
5. SWOT Analysis
6. Technological Know-How and Key Products
7. Acquisitions and Divestitures
8. Marketing Tactics
9. Organization and Management
10. Appendix
List of Tables
Table 1. Stryker — Key Financial Metrics 2023-2025
Table 2. Stryker — Revenue by Segment 2023-2025
Table 3. Stryker — Revenue by Geography 2023-2025
Table 4. Stryker — SWOT Analysis
Table 5. Stryker — Key Products and Platforms 2025
Table 6. Stryker — M&A Activity 2020-2025
Table 7. Stryker — Key Management 2025
Table 8. Stryker — Strategic Priorities 2025-2030
